The global pharmaceutical consumption market was valued at approximately $1.55 trillion in calendar year 2024, advancing to an estimated $1.65 trillion in 2025, the report's base year. Over the 2025-2031 forecast window, the market is projected to expand at a compound annual growth rate of 6.8% in nominal US dollar terms, reaching $2.45 trillion by 2031 - an absolute increment of approximately $795 billion of annual consumption value across the period.
This forecast acceleration is material relative to the historical baseline. The 2022-2024 historical CAGR stood at 4.3%, a comparatively subdued rate reflecting post-COVID-19 normalisation of vaccine demand and inventory destocking. The transition to the 6.8% forward trajectory is underpinned by five discrete structural catalysts, the largest being GLP-1 receptor agonist and cardiometabolic franchise expansion (anchored by semaglutide and tirzepatide), estimated to add approximately $280 billion of incremental consumption value by 2031.
Twenty-five companies are profiled in depth, including Johnson & Johnson, Pfizer, Roche, Merck, AbbVie, Novartis, AstraZeneca, Sanofi, Bristol-Myers Squibb, Eli Lilly, GSK, Novo Nordisk, Takeda, Bayer, Boehringer Ingelheim, Amgen, Gilead, Vertex, Regeneron, Biogen, Moderna, Teva, Viatris, Sun Pharma, and Dr. Reddy's Laboratories.
Scope of Global Pharmaceuticals Industry Strategic Research Report 2026-2031
This research report is ideal for people who wish to gain a thorough understanding of the global pharmaceutical consumption market. Some of the intended users for this report are:
List of Exhibits
Johnson & Johnson, Pfizer, Roche, Merck & Co. (MSD), AbbVie, Novartis, AstraZeneca, Sanofi, Bristol-Myers Squibb, Eli Lilly, GSK, Novo Nordisk, Takeda, Bayer, Boehringer Ingelheim, Amgen, Gilead Sciences, Vertex Pharmaceuticals, Regeneron, Biogen, Moderna, Teva, Viatris, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories
*If Applicable.
NAVADHI is a market research company that helps global firms differentiate themselves, break market entry barriers, track their investments, develop business strategies and plan for future by providing actionable market research intelligence that helps them succeed.